These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?]. Margalit M; Elinav H; Goldin E; Ilan Y Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825 [TBL] [Abstract][Full Text] [Related]
25. Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Siqueira E; Schoen RE; Silverman W; Martin J; Rabinovitz M; Weissfeld JL; Abu-Elmaagd K; Madariaga JR; Slivka A Gastrointest Endosc; 2002 Jul; 56(1):40-7. PubMed ID: 12085033 [TBL] [Abstract][Full Text] [Related]
26. Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis. Vannas MJ; Boyd S; Färkkilä MA; Arola J; Isoniemi H Liver Int; 2017 May; 37(5):735-742. PubMed ID: 28453918 [TBL] [Abstract][Full Text] [Related]
27. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma. Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993 [TBL] [Abstract][Full Text] [Related]
29. A localized primary sclerosing cholangitis preoperatively diagnosed as hilar cholangiocarcinoma; report of a case. Kojima T; Shimura T; Takahashi M; Haga N; Hashimoto S; Fukuda T; Kuwano H Hepatogastroenterology; 2004; 51(58):961-3. PubMed ID: 15239224 [TBL] [Abstract][Full Text] [Related]
30. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation. Cheifetz RE; Davis NL; Owen DA Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617 [TBL] [Abstract][Full Text] [Related]
31. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Abu-Elmagd KM; Selby R; Iwatsuki S; Fung J; Tzakis A; Todo S; Demetris AJ; Baddour N; Irish W; Van Thiel DH Transplant Proc; 1993 Feb; 25(1 Pt 2):1124-5. PubMed ID: 8382850 [No Abstract] [Full Text] [Related]
32. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma. Chung BK; Karlsen TH; Folseraas T Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951 [TBL] [Abstract][Full Text] [Related]
33. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Bergquist A; Glaumann H; Persson B; Broomé U Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625 [TBL] [Abstract][Full Text] [Related]